Skip to main content
. 2014 Dec 10;89(5):2469–2482. doi: 10.1128/JVI.02828-14

TABLE 2.

Viral response upon infection

Sample type and Affymetrix ID Viral gene Expression dataa
2 dpi
3 dpi
4 dpi
Control
Infected
Control
Infected
Control
Infected
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Bursa
    Resistant birds
        NC-004178.CDS1.S1_s_at Segment A, VP5 18.74 25.09 19.5 22.21 15.65 24.87 18.84 15.91 24.51 18.47 19.45 23.08 13.9 18.49 12.25 17.85 16.99
        NC-004178.CDS2.S1_at Segment A, VP2-3-4 17.06 22.05 18.66 16.74 19.59 13.5 19.62 16.09 15.52 9.01 10.9 21.87 8.7 14.86 17.39 16.77 12.15
        NC-004179.CDS1.S1_at Segment B, VP1 8.66 11.6 4.33 14.55 12.24 9.22 0 5.09 5.69 10.99 1.5 3.33 4.48 9.99 7.18 9.95 7.28
    Susceptible birds
        NC-004178.CDS1.S1_s_at Segment A, VP5 19.23 19.07 20.11 9.55 36.78 25.43 24.67 28.2 63.71 108.16 78.07 22.76 19.04 68.55 50.93 64.95
        NC-004178.CDS2.S1_at Segment A, VP2-3-4 15.51 22.04 19.22 15.39 5.95 31.69 29.1 18.29 56.2 72.77 68.43 18.18 17.26 52.09 32.28 47.9
        NC-004179.CDS1.S1_at Segment B, VP1 5.95 5.55 6.1 5.12 11.04 7.05 4.32 3.36 17.49 26.64 26.25 4.34 5.87 14.96 5.07 13.3
Spleen
    Resistant birds
        NC-004178.CDS1.S1_s_at Segment A, VP5 18.71 21.86 22.9 19.1 25.23 24.97 17.98 15.31 26.13 20.16 20.18 16.88 26.93 22.88 21.6 20.54
        NC-004178.CDS2.S1_at Segment A, VP2-3-4 16.11 25.56 27.96 9.89 23.67 26.44 20.82 27.2 21.85 27.13 26.95 20.57 25.71 21.56 22.97 23.91
        NC-004179.CDS1.S1_at Segment B, VP1 4.55 1.14 0 3.05 0.01 3.01 0.01 0 1.8 5.11 0.69 0.98 0 2.93 0.4 0.96
    Susceptible birds
        NC-004178.CDS1.S1_s_at Segment A, VP5 19.62 24.25 24.81 22.11 23.68 18.27 24.89 20.6 19.16 20.15 23.44 31.8 29.72 24.68 20.9 23.82 21.67 18.98
        NC-004178.CDS2.S1_at Segment A, VP2-3-4 17.66 6.83 17.66 19.8 20.62 18.75 21.63 19.46 21.29 29.75 18.58 25.87 18.17 27.85 19.54 27.21 18.84 18.51
        NC-004179.CDS1.S1_at Segment B, VP1 0.75 4.09 3.96 0 0 3.55 2.31 5.9 0 0.17 2.77 0 0.98 0 3.59 1.55 0 0
a

Significant values are indicated in boldface.

HHS Vulnerability Disclosure